Google AdsPeptides & CompoundingAd Rejections

GLP-1 Ads Rejected on Google - Certification and Fixes

Your GLP-1 ads rejected by Google. Discover the exact policy reasons and steps to run compliant GLP-1 campaigns.

April 17, 2026


Google has some of the strictest policies around GLP-1 advertising in the industry. If your GLP-1 ads were rejected, it is usually because your account lacks required healthcare certifications or your landing page does not meet regulatory standards.

We have helped multiple compounding pharmacies get GLP-1 ads running on Google. The process requires more upfront work than Facebook, but Google traffic tends to convert better for peptide and compounding services because users are actively searching.

Why Google Rejects GLP-1 Ads

Google requires advertisers to complete the healthcare and medicines certification before running any ads related to GLP-1 drugs. Without this certification, all GLP-1 related ads are automatically rejected. Google also restricts ads referencing specific prescription drug names, even compounded versions.

Additional rejection reasons include landing pages discussing dosing or administration without a prescription requirement, ads targeting weight loss keywords without proper certification, and copy implying treatment efficacy.

Regulatory Standards for GLP-1 Advertising

FDA 503A is the primary framework for compounded GLP-1 advertising. Google expects your ads and landing pages to reflect that your products are compounded per individual prescriptions, not manufactured and sold as standardized treatments.

FDA 503B covers larger-scale compounding facilities. If you operate under 503B, include additional disclaimers about sterility and quality assurance.

Google's healthcare policy requires all health-related ads be truthful, not misleading, and compliant with all applicable laws. The BAV appeal pathway also applies to Google for business verification.

How We Fix Google Rejections

Get healthcare certified. Apply for Google's healthcare and medicines certification. Submit your pharmacy license, business registration, and a signed declaration that your ads comply with applicable laws.

Restructure your landing page. Remove any language implying GLP-1 drugs are available without a prescription. Add clear disclaimers about FDA 503A compounding and the requirement for a medical consultation.

Use category-level keywords. Instead of targeting branded GLP-1 drug names, use keywords like compounded weight management, peptide therapy consultation, or GLP-1 compounding pharmacy.

Appeal with documentation. When appealing, attach your healthcare certification, pharmacy license, and a compliance summary explaining how your business follows FDA 503A or 503B regulations.

Case Study: Google Campaign Launched Successfully

A compounding pharmacy wanted to run Google Ads for their GLP-1 compounding services. Their initial ads were rejected for unapproved pharmaceutical advertising. We guided them through the Google healthcare certification process, rebuilt their landing page to focus on consultation services, and submitted a detailed reconsideration request. The campaign went live within 10 business days and generated a 4x ROAS in the first month.

Related reads

Peptide Ads Rejected on Google

GLP-1 Ads Banned on Facebook

Ready to run these ads? Book a call at calendly.com/custodio-2/30min

Related Resources